Plain-English translation of NCT04602338 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is testing whether three different heart imaging techniques—cardiac magnetic resonance imaging, echocardiography (ultrasound), and nuclear medicine imaging—can better identify and diagnose a specific type of heart failure called HFpEF, where the heart's pumping strength looks normal on standard tests but the heart still isn't working as well as it should. Researchers want to understand which imaging method works best to catch this condition early and predict which patients are at higher risk. This study involves 1,000 patients across multiple hospitals in China.
HFpEF is becoming more common, especially in older adults and people with conditions like high blood pressure and diabetes, but doctors currently struggle to diagnose it early because standard tests often look normal. There is no proven treatment yet, so finding better ways to identify this condition early could help doctors treat patients sooner and improve their health outcomes.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would undergo three different imaging tests of your heart: an MRI scan (magnetic resonance imaging), an ultrasound (echocardiography), and a nuclear medicine scan. These are all non-invasive tests that create pictures of your heart to show its structure and function. The study will follow your health outcomes over time to see which imaging methods best predict who gets sicker and who stays stable.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China